RxDoctor Payments Data

Gloria Gerber, MD

Hematology · Baltimore, MDNPI 1023462462

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $36,220 of the $40,502 with a category attached, or 89.4%. AstraZeneca accounts for 77.3% of it on its own, with 4 other manufacturers making up the rest.

$40,502in general payments, 2019–2025

Across 31 payments — averaging $1306.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$31K
  • Merck$8K
  • Novartis$690
  • Bristol Myers Squibb$500
  • Sobi, Inc$245

What the payments were for

  • Consulting fees$36,22089%
  • Speaking & faculty fees$5001%
  • Travel & lodging$3,0478%
  • Food & beverage$4911%
  • Education$2451%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca23$31,317
Merck3$7,750
Novartis1$690
Bristol Myers Squibb1$500
Sobi, Inc3$245

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,502 in reported general payments places this provider in the 85th percentile of 28 hematology providers in Maryland.

See all hematology providers in Maryland

Medicare billing

Part B allowed, 2024
$16,602
Medicare patients
66
Services billed
122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →